Literature DB >> 20883163

Programmed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infection.

Ashley D Frazier1, Chun L Zhang, Lei Ni, Cheng J Ma, Ying Zhang, Xiao Y Wu, Antwan N Atia, Zhi Q Yao, Jonathan P Moorman.   

Abstract

Chronic hepatitis C virus (HCV) infection is associated with T-cell exhaustion that is mediated through upregulation of the PD-1 negative regulatory pathway. PD-1 expression is induced by HCV core protein, which also induces upregulation of SOCS-1, a key modulator that controls the Jak/STAT pathway regulating cytokine expression. To determine whether these two negative regulatory pathways are linked during T-cell signaling, SOCS-1 expression was examined by blocking the PD-1 pathway in T cells stimulated with anti-CD3/CD28 in the presence of HCV core protein. T cells isolated from healthy subjects or HCV-infected individuals were treated with anti-PD-1 or anti-PDL-1 antibodies in the presence or absence of HCV core protein, and SOCS-1 gene expression was detected by RT-PCR or immunoblotting, while T-cell functions were assayed by flow cytometric analyses. Both PD-1 and SOCS-1 gene expression were upregulated in healthy T cells exposed to HCV core protein, and blocking the PD-1 pathway downregulated SOCS-1 gene expression in these cells. Additionally, T cells isolated from chronically HCV-infected subjects exhibited increased PD-1 and SOCS-1 expression compared to healthy subjects, and SOCS-1 expression in T cells isolated from HCV-infected subjects was also inhibited by blocking PD-1 signaling; this in turn enhanced the phosphorylation of STAT-1, and improved the impaired T-cell proliferation observed in the setting of HCV infection. These data demonstrate that PD-1 and SOCS-1 are linked in dysregulating T-cell signaling during HCV infection, and their cross-talk may coordinately inhibit T-cell signaling pathways that lead to T-cell exhaustion during chronic viral infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20883163      PMCID: PMC2967821          DOI: 10.1089/vim.2010.0010

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  27 in total

1.  Hepatitis C: the complications of immune dysfunction.

Authors:  Ellis King; Christopher Trabue; Deling Yin; Zhi Q Yao; Jonathan P Moorman
Journal:  Expert Rev Clin Immunol       Date:  2007-03       Impact factor: 4.473

2.  Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines.

Authors:  Yasuteru Kondo; Vicky M H Sung; Keigo Machida; Minyi Liu; Michael M C Lai
Journal:  Virology       Date:  2006-12-18       Impact factor: 3.616

3.  Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.

Authors:  K M Chang; B Rehermann; J G McHutchison; C Pasquinelli; S Southwood; A Sette; F V Chisari
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

4.  RSV replication is attenuated by counteracting expression of the suppressor of cytokine signaling (SOCS) molecules.

Authors:  Koichi Hashimoto; Kei Ishibashi; Ken Ishioka; Dongchi Zhao; Masatoki Sato; Shinichiro Ohara; Yusaku Abe; Yukihiko Kawasaki; Yuka Sato; Shin-Ichi Yokota; Nobuhiro Fujii; Ray Stokes Peebles; Mitsuaki Hosoya; Tatsuo Suzutani
Journal:  Virology       Date:  2009-07-12       Impact factor: 3.616

5.  Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.

Authors:  B Rehermann; K M Chang; J G McHutchison; R Kokka; M Houghton; F V Chisari
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

6.  Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.

Authors:  Lucy Golden-Mason; Brent Palmer; Jared Klarquist; John A Mengshol; Nicole Castelblanco; Hugo R Rosen
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

7.  A screening method for identifying disruptions in interferon signaling reveals HCV NS3/4a disrupts Stat-1 phosphorylation.

Authors:  Karla J Helbig; Evelyn Yip; Erin M McCartney; Nicholas S Eyre; Michael R Beard
Journal:  Antiviral Res       Date:  2007-12-26       Impact factor: 5.970

8.  Abnormal B-cell activation associated with TALL-1 over-expression and SOCS-1 suppression during chronic hepatitis C virus infection.

Authors:  Jonathan Moorman; Zhi P Dong; Lei Ni; Chunlan Zhang; Thomas Borthwick; Zhi Q Yao
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

9.  Differential regulation of SOCS-1 signalling in B and T lymphocytes by hepatitis C virus core protein.

Authors:  Zhi Qiang Yao; Deborah Prayther; Christopher Trabue; Zhi Ping Dong; Jonathan Moorman
Journal:  Immunology       Date:  2008-04-04       Impact factor: 7.397

10.  Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences.

Authors:  Lucy Golden-Mason; Jared Klarquist; Abdus S Wahed; Hugo R Rosen
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

View more
  16 in total

1.  PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection.

Authors:  Wen Xiao; Long Feng Jiang; Xiao Zhao Deng; Dan Yan Zhu; Jia Ping Pei; Mao Lei Xu; Bing Jun Li; Chang Jun Wang; Jing Hai Zhang; Qi Zhang; Zhen Xian Zhou; Wei Liang Ding; Xiao Dong Xu; Ming Yue
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

2.  Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses.

Authors:  Jonathan P Moorman; Chun L Zhang; Lei Ni; Cheng J Ma; Ying Zhang; Xiao Y Wu; Penny Thayer; Tareq M Islam; Thomas Borthwick; Zhi Q Yao
Journal:  Vaccine       Date:  2011-03-03       Impact factor: 3.641

Review 3.  Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?

Authors:  Barbara Vannata; Luca Arcaini; Emanuele Zucca
Journal:  Ther Adv Hematol       Date:  2015-12-29

4.  Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection.

Authors:  Jonathan P Moorman; Jia M Wang; Ying Zhang; Xiao J Ji; Cheng J Ma; Xiao Y Wu; Zhan S Jia; Ke S Wang; Zhi Q Yao
Journal:  J Immunol       Date:  2012-06-15       Impact factor: 5.422

5.  The relevance of Tim-3 polymorphisms and F protein to the outcomes of HCV infection.

Authors:  J P Pei; L F Jiang; X W Ji; W Xiao; X Z Deng; Z X Zhou; D Y Zhu; W L Ding; J H Zhang; C J Wang; K Jing
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-26       Impact factor: 3.267

Review 6.  Dendritic cells: The warriors upfront-turned defunct in chronic hepatitis C infection.

Authors:  Meenakshi Sachdeva; Yogesh K Chawla; Sunil K Arora
Journal:  World J Hepatol       Date:  2015-09-08

7.  Tim-3 alters the balance of IL-12/IL-23 and drives TH17 cells: role in hepatitis B vaccine failure during hepatitis C infection.

Authors:  Jia M Wang; Cheng J Ma; Guang Y Li; Xiao Y Wu; Penny Thayer; Pamela Greer; Ashley M Smith; Kevin P High; Jonathan P Moorman; Zhi Q Yao
Journal:  Vaccine       Date:  2013-03-14       Impact factor: 3.641

Review 8.  Production and pathogenicity of hepatitis C virus core gene products.

Authors:  Hui-Chun Li; Hsin-Chieh Ma; Chee-Hing Yang; Shih-Yen Lo
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 9.  Immune exhaustion and immune senescence: two distinct pathways for HBV vaccine failure during HCV and/or HIV infection.

Authors:  Zhi Q Yao; Jonathan P Moorman
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-02-12       Impact factor: 4.291

10.  Apoptosis - an Ubiquitous T cell Immunomodulator.

Authors:  Anuradha K Murali; Shikhar Mehrotra
Journal:  J Clin Cell Immunol       Date:  2011-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.